Payment underwriting is an assessment of the business a provider is being asked to support. The strongest application is a clear, accurate account of the products, customers and operating controls. It is not a search for wording that disguises the activity.

Stripe’s restricted-business policy describes additional diligence for some categories, while its peptide FAQ gives more specific conditions for research and pharmaceutical sales. The assessment remains dependent on the actual business model. Stripe prohibited and restricted businesses policy Stripe prohibited and restricted businesses FAQ

Explain the catalog and intended use

An underwriting file should make the product categories understandable and distinguish research materials from prescription products or consumer goods. The description should agree with the website, marketing, invoices and fulfillment process. Contradictory claims create questions that a disclaimer cannot resolve.

For a genuinely research-focused business, document who the customers are and how the stated intended use is reflected in practice. If the provider asks about controls, answer with the controls that actually exist. Do not invent screening, testing or regulatory approval to obtain an account.

Make customer outcomes traceable

Clear contact information, fulfillment expectations, refund terms and dispute handling help the provider understand operational risk. Supporting records should be organized enough to explain a specific order without exposing unnecessary personal information.

The file should also identify what would trigger a new review: adding a product type, entering another jurisdiction or materially changing marketing claims. Approval of one version of the business should not be interpreted as approval of every future expansion.

AXON’s approach is to treat underwriting as a continuing documentation task. Preserve the submitted description and written response, then keep them aligned with operations. If a provider declines the activity, address the stated reason or seek a provider that knowingly supports the model. Misclassification and hidden routing are not substitutes for approval.